Keyword,Priority
adenovirus,High
Any new targets for SCLC,Medium
BNT327 or BNT-327 or PM8002,Medium
BNT327 or BNT-327 or PM8002,Medium
BNT327 or BNT-327 or PM8002,Medium
BNT327 or BNT-327 or PM8002,Medium
BNT327 or BNT-327 or PM8002,Medium
BNT327 or BNT-327 or PM8002,Medium
CRAF degrader,Medium
DLL3,High
EGFR degrader or PROTAC,High
ENPP3,High
IBI-363 or IBI363,Medium
KRAS-G12C,High
KRAS-G12D,High
Mesothelin or MSLN,Medium
Non-Small Cell Lung Cancer,High
Non-Small Cell Lung Cancer,High
oHSV,High
oncolytic virus,High
Pan-KRAS,High
Pan-RAS,High
PD-1/IL-15 or IL-15/PD-1,Medium
PD-1/IL-2 or IL-2/PD-1,Medium
PTK7,Medium
Radioenhancer,High
Radioligands,High
Radiotherapeutics,High
Rivelgostomig or AZD-2936 or AZD2936,Medium
Rivelgostomig or AZD-2936 or AZD2936,Medium
SSGJ-707,Medium
TAOK1,Medium
Volrustomig or MEDI5752 or MEDI-5752,Medium
Volrustomig or MEDI5752 or MEDI-5752,Medium
